These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Sensorimotor Characteristics of Neuro-Ophthalmology and Oculo-Plastics Patients. Christoff A Am Orthopt J; 2015; 65():47-57. PubMed ID: 26564927 [TBL] [Abstract][Full Text] [Related]
11. Co-occurrence of Convergence Insufficiency and Cognitive Impairment in Parkinsonian Disorders: A Pilot Study. Holden SK; Van Dok E; Pelak VS Front Neurol; 2019; 10():864. PubMed ID: 31447772 [No Abstract] [Full Text] [Related]
12. Impulse Control Disorders in Parkinson's Disease and Atypical Parkinsonian Syndromes-Is There a Difference? Toś M; Grażyńska A; Antoniuk S; Siuda J Brain Sci; 2024 Feb; 14(2):. PubMed ID: 38391755 [TBL] [Abstract][Full Text] [Related]
13. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation. Santos García D; Jesús S; Aguilar M; Planellas LL; García Caldentey J; Caballol N; Legarda I; Hernández Vara J; Cabo I; López Manzanares L; González Aramburu I; Ávila Rivera MA; Catalán MJ; López Díaz L; Puente V; García Moreno JM; Borrué C; Solano Vila B; Álvarez Sauco M; Vela L; Escalante S; Cubo E; Carrillo Padilla F; Martínez Castrillo JC; Sánchez Alonso P; Alonso Losada MG; López Ariztegui N; Gastón I; Kulisevsky J; Menéndez González M; Seijo M; Rúiz Martínez J; Valero C; Kurtis M; de Fábregues-Boixar O; González Ardura J; Prieto Jurczynska C; Martinez-Martin P; Mir P; Eur J Neurol; 2019 Nov; 26(11):1399-1407. PubMed ID: 31179586 [TBL] [Abstract][Full Text] [Related]
14. Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease. Ling H; Massey LA; Lees AJ; Brown P; Day BL Brain; 2012 Apr; 135(Pt 4):1141-53. PubMed ID: 22396397 [TBL] [Abstract][Full Text] [Related]
16. Community-based care for the specialized management of heart failure: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2009; 9(17):1-42. PubMed ID: 23074521 [TBL] [Abstract][Full Text] [Related]
17. Deep brain stimulation of the pedunculopontine nucleus for treatment of gait and balance disorder in progressive supranuclear palsy: Effects of frequency modulations and clinical outcome. Galazky I; Kaufmann J; Lorenzl S; Ebersbach G; Gandor F; Zaehle T; Specht S; Stallforth S; Sobieray U; Wirkus E; Casjens F; Heinze HJ; Kupsch A; Voges J Parkinsonism Relat Disord; 2018 May; 50():81-86. PubMed ID: 29503154 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and Risk Factors for Double Vision in Parkinson Disease. Hamedani AG; Maguire MG; Marras C; Willis AW Mov Disord Clin Pract; 2021 Jul; 8(5):709-712. PubMed ID: 34307743 [TBL] [Abstract][Full Text] [Related]
19. Intrastromal corneal ring implants for corneal thinning disorders: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2009; 9(1):1-90. PubMed ID: 23074513 [TBL] [Abstract][Full Text] [Related]
20. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]